摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(3,6-dichloropyridazin-4-yl)ethanone | 1393557-96-4

中文名称
——
中文别名
——
英文名称
1-(3,6-dichloropyridazin-4-yl)ethanone
英文别名
——
1-(3,6-dichloropyridazin-4-yl)ethanone化学式
CAS
1393557-96-4
化学式
C6H4Cl2N2O
mdl
——
分子量
191.017
InChiKey
ULSBGXGBXJVHJH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    42.8
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    1-(3,6-dichloropyridazin-4-yl)ethanone盐酸甲醇1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物caesium carbonate 作用下, 以 1,4-二氧六环仲丁醇 为溶剂, 反应 3.0h, 生成 5-(1,3-dimethylpyrazolo[3,4-c]pyridazin-5-yl)-1H-pyrimidine-2,4-dione
    参考文献:
    名称:
    [EN] HETEROARYL COMPOUNDS FOR THE TREATMENT OF CANCER
    [FR] COMPOSÉS HÉTÉROARYLE POUR LE TRAITEMENT DU CANCER
    摘要:
    The present invention relates to compounds of formula (I), wherein A1to A7and W are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.
    公开号:
    WO2024033454A1
  • 作为产物:
    描述:
    3,6-Dichloro-4-prop-1-en-2-ylpyridazine 在 ruthenium trichloride 、 sodium periodate 作用下, 以 四氢呋喃丙酮 为溶剂, 以0.40 g的产率得到1-(3,6-dichloropyridazin-4-yl)ethanone
    参考文献:
    名称:
    [EN] HETEROARYL COMPOUNDS FOR THE TREATMENT OF CANCER
    [FR] COMPOSÉS HÉTÉROARYLE POUR LE TRAITEMENT DU CANCER
    摘要:
    The present invention relates to compounds of formula (I), wherein A1to A7and W are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.
    公开号:
    WO2024033454A1
点击查看最新优质反应信息

文献信息

  • FUSED IMIDAZOLE DERIVATIVE HAVING TTK INHIBITORY ACTION
    申请人:Kusakabe Ken-ichi
    公开号:US20120059162A1
    公开(公告)日:2012-03-08
    Provided are a compound represented by general formula (1) and having a TTK inhibitory action and a medicine containing the compound. In formula (1), (X, Y, V, W) is (—N═, ═CR 1 —, ═N—, —CR 7 ═), (—CR 2 ═, ═N—, ═N—, —CR 7 ═), etc.; A is an (un)substituted aromatic hydrocarbon ring, etc.; L is a single bond, —C(═O)—NR A —, etc.; Z is a group represented by the formula —NR 3 R 4 or a group represented by the formula —OR 5 ; R 1 to R 3 , R 6 , and R 7 each is a hydrogen atom, etc.; R 4 and R 5 each is an (un)substituted alkyl, etc.; and R 8 is an (un)substituted cycloalkyl, etc.
    提供了一个由一般式(1)表示的化合物,具有TTK抑制作用,以及含有该化合物的药物。在式(1)中,(X,Y,V,W)为(—N═,═CR1—,═N—,—CR7═),(—CR2═,═N—,═N—,—CR7═),等等;A为(非)取代芳香烃环等;L为一个单键,—C(═O)—NRA—等;Z为由式—NR3R4或式—OR5表示的基团;R1至R3,R6和R7分别是氢原子等;R4和R5分别是(非)取代烷基等;R8是(非)取代环烷基等。
  • [EN] 1 -(PYRIDAZIN-3-YL)-IMIDAZOLIDIN-2-ONE DERIVATIVES AS HERBICIDES<br/>[FR] DÉRIVÉS DE 1 -(PYRIDAZIN-3-YL)-IMIDAZOLIDIN-2-ONE EN TANT QU'HERBICIDES
    申请人:SYNGENTA PARTICIPATIONS AG
    公开号:WO2015067701A1
    公开(公告)日:2015-05-14
    The invention relates to pyrrolone compounds of the formula (I) wherein R1, R2, R3, Rb, Rc and Rd are as defined in the specification. Furthermore, the present invention relates to processes and intermediates for making compounds of formula (I), to herbicidal compositions comprising these compounds and to methods of using these compounds to control plant growth.
    该发明涉及式(I)的吡咯酮化合物,其中R1、R2、R3、Rb、Rc和Rd如规范中所定义。此外,本发明涉及制备式(I)化合物的过程和中间体,包括这些化合物的除草剂组合物以及使用这些化合物控制植物生长的方法。
  • [EN] 6,7-DIAZAINDAZOLE AND 6,7-DIAZAINDOLE DERIVATIVES AND USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA THEREOF<br/>[FR] DÉRIVÉS DE 6,7-DIAZAINDAZOLE ET DE 6,7-DIAZAINDOLE ET LEUR UTILISATION DANS LE TRAITEMENT, L'ATTÉNUATION DES SYMPTÔMES OU LA PRÉVENTION DE LA GRIPPE
    申请人:SAVIRA PHARMACEUTICALS GMBH
    公开号:WO2017133665A1
    公开(公告)日:2017-08-10
    Provided herein is a compound of formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, prodrug, codrug, cocrystal, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, which is useful in treating, ameliorating or preventing influenza.
    本文提供的是一种化合物,其化学式为(I),可选地以药用盐、溶剂合物、多型体、前药、共药、共晶体、互变异构体、消旋体、对映体或二对映体或其混合物的形式存在,可用于治疗、改善或预防流感。
  • REACTIVE LEUCO COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME
    申请人:Milliken & Company
    公开号:US20180118942A1
    公开(公告)日:2018-05-03
    A leuco composition comprises at least one reactive leuco compound, which reactive leuco compound comprises a leuco moiety and at least one reactive moiety covalently bound to the leuco moiety. A laundry care composition comprises a laundry care ingredient and a leuco composition. A method of treating a textile comprises the steps of (i) treating a textile with an aqueous solution containing a leuco composition, (ii) optionally, rinsing the textile, and (iii) drying the textile.
    一种白色组合物包括至少一种反应性白色化合物,所述反应性白色化合物包括白色基团和至少一个与白色基团共价结合的反应性基团。一种洗涤护理组合物包括洗涤护理成分和白色组合物。一种处理纺织品的方法包括以下步骤:(i) 用含有白色组合物的溶液处理纺织品,(ii) 可选地,冲洗纺织品,以及(iii) 干燥纺织品。
  • 1-(PYRIDAZIN-3-YL)-IMIDAZOLIDIN-2-ONE DERIVATIVES AS HERBICIDES
    申请人:SYNGENTA PARTICIPATIONS AG
    公开号:US20160262395A1
    公开(公告)日:2016-09-15
    The invention relates to pyrrolone compounds of the formula (I) wherein R 1 , R 2 , R 3 , R b , R c and R d are as defined in the specification. Furthermore, the present invention relates to processes and intermediates for making compounds of formula (I), to herbicidal compositions comprising these compounds and to methods of using these compounds to control plant growth.
    本发明涉及式(I)的吡咯烷化合物,其中R1,R2,R3,Rb,Rc和Rd如规范中所定义。此外,本发明涉及制备式(I)化合物的过程和中间体,包括这些化合物的除草剂组合物以及使用这些化合物控制植物生长的方法。
查看更多